IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical FIN Neth SR Glbl NT 25

Q3 2023 vs Q4 2023

Comparing institutional holders between quarters

Quarters

Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Pacer Advisors, Inc.
UNCHANGED
Shares99,000 from 99,000
Change0 (0%)
Value$100.0K (+$747)
Filed 2024-01-16
Status
Pacer Advisors, Inc.
UNCHANGED99,00099,00000%$99.2K$100.0K+$7472024-01-16
Showing 1 of 1 institutions